Modafinil for Sleep Disorders: Recommended Use and Dosing
Introduction to Modafinil
- The American Academy of Sleep Medicine recommends modafinil as the first-line treatment for excessive daytime sleepiness in narcolepsy, with a standard dose of 200 mg taken once daily in the morning, which can be increased to 400 mg daily if needed 1
FDA-Approved Indications
- Modafinil is FDA-approved for narcolepsy (excessive daytime sleepiness) 2
Standard Dosing Protocols
- The American Geriatrics Society recommends a starting dose of 100 mg once upon awakening in the morning for elderly patients, with titration at weekly intervals as necessary, and a typical maintenance range of 200-400 mg per day 2
Clinical Efficacy Evidence
- The American Academy of Sleep Medicine provides a strong recommendation for modafinil in narcolepsy based on moderate-quality evidence from 9 randomized controlled trials and 4 observational studies, with clinically significant improvements in excessive daytime sleepiness, disease severity, and quality of life 1
- Modafinil does not suppress cataplexy, requiring separate treatment with antidepressants or sodium oxybate 2
- Modafinil maintains nocturnal sleep architecture without disrupting nighttime sleep 2
Important Safety Considerations
- Common adverse effects of modafinil include headache, nausea, nervousness, insomnia, diarrhea, dry mouth, back pain, anxiety, dizziness, and dyspepsia 1, 2, 4
- The American Academy of Sleep Medicine recommends monitoring blood pressure, heart rate, and cardiac rhythm when initiating or adjusting modafinil doses, with a watch for hypertension, palpitations, and arrhythmias 2
Pharmacokinetic Properties
- Modafinil has a half-life of approximately 15 hours, with a time to steady state of 2-4 days of dosing, and a peak plasma concentration of 2-3 hours after oral administration 4
Monitoring During Treatment
- The American Geriatrics Society recommends frequent follow-up when starting or adjusting modafinil doses, with assessment for excessive stimulatory effects, nocturnal sleep disturbances, and behavioral changes, including psychosis 2